ovarian cancer

2023 ASCO Annual Meeting; #ASCO23
August 17, 2023 · Brielle Gregory Collins, ASCO staff
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in ovarian cancer, uterine cancer, cervical cancer, multiple myeloma, and head and neck cancer. Read More >>
July 13, 2023 · Kate Ruder
Some people may have concerns over whether using hair dyes or hair relaxers can impact their cancer risk. Here, learn more about permanent coloring and straightening products and their possible links to cancer, particularly when used frequently. Read More >>
2023 ASCO Annual Meeting; #ASCO23
June 4, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6. Several notable studies will be presented today. Topics include radiation therapy in rectal cancer, osimertinib for lung cancer, vorasidenib for grade 2 glioma, nivolumab for Hodgkin lymphoma, and mirvetuximab soravtansine for ovarian cancer. Read More >>
2023 ASCO Annual Meeting; #ASCO23
June 3, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6. A study that will be presented today explores combining immunotherapy and targeted therapy to reduce the risk of death and recurrence for people with advanced ovarian cancer. Read More >>
November 15, 2022 · Kate Ruder
Fertility drugs are used to help a person become pregnant and may be used with other fertility treatments, such as in vitro fertilization (IVF). But could these drugs increase a person’s risk for developing cancer? Are they safe to use if you have cancer? Here, learn what the research says about fertility drugs and cancer risk. Read More >>